ACORN BIOVENTURES, L.P. - 23 Jan 2026 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol
JSPR
Shares outstanding
28,047,019 shares
Disclosed Ownership
1,486,492 shares
Ownership
5.3%
Form type
SCHEDULE 13G/A
Filing time
26 Jan 2026, 15:29:02 UTC
Date of event
23 Jan 2026
Previous filing
02 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ACORN BIOVENTURES, L.P. disclosed 5.3% ownership in Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR) on 23 Jan 2026."

Quick Takeaways

  • ACORN BIOVENTURES, L.P. filed SCHEDULE 13G/A for Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR).
  • Disclosed ownership: 5.3%.
  • Date of event: 23 Jan 2026.

What Changed

  • Previous schedule filing date: 02 Dec 2025.
  • Current filing was accepted on 26 Jan 2026, 15:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 624,326 0 624,326 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 624,326 0 624,326 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3.1% 862,166 0 862,166 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 3.1% 862,166 0 862,166 Anders Hove Manager
Anders Hove 5.3% 1,486,492 0 1,486,492 Anders Hove Individually

Sponsored